Status:
COMPLETED
Non-Hodgkin Lymphoma in Elderly Patients Above the Age of 80 in the Rituximab Era
Lead Sponsor:
Oncology Specialists, S.C.
Conditions:
Non-Hodgkin's Lymphoma
Eligibility:
All Genders
80-80 years
Brief Summary
This is an exploratory analysis that is investigating the pattern of care in patients over the age of 80 who were diagnosed with non-Hodgkin lymphoma (NHL). This study will look at the dose intensity ...
Detailed Description
Non-Hodgkin Lymphoma (NHL) is a malignant disease of the lymphoid and hematopoetic system with an annual incidence of 60,000 cases/year in the United States accounting for over 18,000 deaths annually....
Eligibility Criteria
Inclusion
- Patients with any NHL diagnosis regardless of histology who are over the age of 80 at the time of diagnosis will be included and analyzed.
- Data on age, gender, performance status, and major co-morbid conditions will be collected.
- Histology of the diagnosed NHL will be recorded. The grade (1, 2, or 3) for those who were diagnosed with follicular lymphoma will also be recorded.
- Stage of the disease, presence of bulky nodes and B symptoms will also be recorded.
- PET scan results if available.
- Type of treatment received will be recorded.
- Responses to therapy.
- Outcomes of treatment implemented and toxicities incurred.
- Subsequent therapies if applicable.
Exclusion
- None. All charts of patients who are above the age of 80 at the time of NHL diagnosis will be analyzed.
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00902434
Start Date
May 1 2009
End Date
April 1 2011
Last Update
July 1 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.